Skip to main content
Log in

Commercialisation of genetic diagnostic services

  • Published:
Medicine, Health Care and Philosophy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Adler, R.A.: 1992, ‘Genome research: Fulfilling the public's expectation for knowledge and commercialisation’, Science257, pp. 908–914.

    PubMed  CAS  Google Scholar 

  • Advisory Committee on Genetic testing (ACGT): 1997, Code of Practice and Guidance on Human Genetic Testing Services Supplied Direct to the Public. London: Health Departments of the United Kingdom.

    Google Scholar 

  • Anderson, C.: 1993, ‘Genome project goes commercial’, Science259, pp. 300–302.

    PubMed  CAS  Google Scholar 

  • Andrews, L.B. et al. (eds.): 1994, Assessing Genetic Risks: Implications for Health and Social Policy. Washington D.C.: Institute of Medicine, National Academy Press.

    Google Scholar 

  • Anonymous: 1997, ‘Genomics wheelers and dealers’, Science275, pp. 774–775.

    Article  Google Scholar 

  • Beauchamp, T.L. and N.E. Bowie (eds): 1993, Ethical Theory and Business. Englewood Cliffs, New Jersey: Prentice Hall Inc.

    Google Scholar 

  • Biesecker, B.B. et al.: 1993, ‘Genetic counselling for families with inherited susceptibility to breast and ovarian cancer’, Journal of the American Medical Association269, pp. 1970–1974.

    Article  PubMed  CAS  Google Scholar 

  • Blumenthal, D.: 1992, ‘Academic-industry relationships in the life sciences’, Journal of the American Medical Association268, pp. 3344–3349.

    Article  PubMed  CAS  Google Scholar 

  • Blumenthal, D. et al.: 1997, ‘Withholding research results in academic life science’, Journal of the American Medical Association227, pp. 1224–1228.

    Article  Google Scholar 

  • Boatright, J.R.: 1993, Ethics and the Conduct of Business. Englewood Cliffs, New Jersey: Prentice Hall.

    Google Scholar 

  • Breo, D.L.: 1993, ‘Altered fates. Counselling families with inherited breast cancer’, Journal of the American Medical Association269, pp. 2017–2022.

    Article  PubMed  CAS  Google Scholar 

  • Brower, V.: 1997, ‘Testing, testing... testing?’ Nature Medicine3, pp. 131–132.

    Article  CAS  Google Scholar 

  • Bull, S.: 1996, ‘Mail order gene testing’, Bulletin of Medical Ethics(February), pp. 20–21.

  • Burke, W. et al.: 1997, ‘Recommendations for follow-up of individuals with an inherited predisposition to cancer’, Journal of the American Medical Association277, pp. 997–1003.

    Article  PubMed  CAS  Google Scholar 

  • Clarke, A. (ed.): 1994, ‘Introduction’. In: Genetic Counselling: Practice and Principles. London: Routledge.

    Google Scholar 

  • Cohen, J.: 1997, ‘The genomics gamble’, Science275, pp. 767–772.

    Article  PubMed  CAS  Google Scholar 

  • Danish Council of Ethics: 1993, Ethics and Mapping of the Human Genome. Copenhagen: Danish Council of Ethics.

    Google Scholar 

  • Dausset, J.: 1996, ‘Predictive medicine’, European Journal of Obstetrics, Gynaecology and Reproductive Biology65, pp. 29–32.

    Article  CAS  Google Scholar 

  • Ducor, P.: 1997, ‘Are patents and research compatible’, Nature387 (1 May), pp. 13–14.

  • Editorial: 1996, ‘Capitalising on the genome’, Nature Genetics13, pp. 1–5.

    Article  Google Scholar 

  • Eisenberg, R.S.: 1992a, ‘Genes, patents, and product development’, Science257, pp. 903–908.

    PubMed  CAS  Google Scholar 

  • Eisenberg, R.S.: 1992b, ‘Patent rights in the human genome project’. In: Gene Mapping: Using Law and Ethics as Guides. New York: Oxford University Press.

    Google Scholar 

  • Eisenberg, R.S.: 1997, ‘Structure and function in gene patenting’, Nature Genetics15, pp. 125–130.

    Article  PubMed  CAS  Google Scholar 

  • Health Council of the Netherlands, Committee DNADiagnostics: 1998, DNA-Diagnostiek, Rijswijk: Health Council (1998/11).

    Google Scholar 

  • Holtzman, N.A. and M.S. Watson: 1997, Promoting Safe and Effective Genetic testing in the United States, Final Report of the Task Force on Genetic testing. Baltimore: John Hopkins University Press.

    Google Scholar 

  • Holtzman, N.A. et al.: 1997, ‘Predictive genetic testing: from basic research to clinical practice’, Science278, pp. 602–604.

    Article  PubMed  CAS  Google Scholar 

  • Hubbard, R. and E. Wald: 1993, Exploding the Gene Myth: How Genetic Information is Produced and Manipulated by Scientists, Physicians, Employers, Insurance Companies, Educators and Law Enforcers. Boston: Beacon Press.

    Google Scholar 

  • Jones, R.: 1996, ‘The impact of molecular medicine on health services’, Nature Medicine2, pp. 959–960.

    Article  PubMed  CAS  Google Scholar 

  • Jonson, A.R. et al.: 1996, ‘The advent of the unpatients’, Nature Medicine2, pp. 622–624.

    Article  Google Scholar 

  • Joyce, C.: 1987, ‘Genes reach the medical market’, New Scientist115 (16 July), pp. 45–49.

  • Kahn, P.: 1996, ‘Coming to grips with genes and risk’, Science274, pp. 496–498.

    Article  PubMed  CAS  Google Scholar 

  • King, M.C., S. Roweland and S.M. Love: 1993, ‘Inherited breast and ovarian cancer. What are the risks? What are the choices?’ Journal of the American Medical Association269, pp. 1975–1980.

    Article  PubMed  CAS  Google Scholar 

  • Marcus, A.: 1996, ‘Owning a gene: patent pending’, Nature Medicine2, pp. 728–729.

    Article  CAS  Google Scholar 

  • Marshall, E.: 1996, ‘ELSI’s cystic fibrosis experiment’, Science274, p. 489.

    Article  CAS  Google Scholar 

  • Marshall, E.: 1997, ‘Is data-hoarding slowing the assault on pathogens?’ Science275, pp. 777–780.

    Article  PubMed  CAS  Google Scholar 

  • Milunski, A.: 1992, ‘Threatened survival of academic-based genetic laboratory services’, American Journal of Human Genetics50, pp. 643–645.

    Google Scholar 

  • Nuffield Council on Bioethics: 1993, Genetic Screening: Ethical Issues. London: Nuffield Council on Bioethics.

    Google Scholar 

  • Roberts, L.: 1990, ‘To test or not to test?’ Science247, pp. 17–19.

    PubMed  CAS  Google Scholar 

  • Taupitz, J.: 1993, ‘Kommerzialisierung menschlicher Körpersubstanzen’. In: R. Damm and D. Hart (eds.), Rechtliche Regulierung von Gesundheidsrisiken. Baden-Baden: Nomos Verl. Ges., pp. 51–93.

    Google Scholar 

  • Tibben, A.: 1993, What is Knowledge but Grieving? On Psychological Effects of Presymptomatic DNA-testing for Huntingdon’s Disease. Rotterdam: Universiteitsdrukkerij Erasmus.

    Google Scholar 

  • Trigg, M.E. and M.R. Geier: 1992, ‘On the relationship between academic and private genetic services’, American Journal of Human Genetics51, pp. 890–891.

    PubMed  CAS  Google Scholar 

  • U.S. Congress, Office of Technology Assessment (OTA): 1991, Biotechnology in a Global Economy. Washington, D.C.: U.S. Government Printing Office.

    Google Scholar 

  • Vallance, E.: 1995, Business Ethics at Work. Cambridge: Cambridge University Press.

    Google Scholar 

  • Wilfond, B.S. and K. Nolan: 1993, ‘National policy development for the clinical application of genetic diagnostic services: lessons from cystic fibrosis’, Journal of the American Medical Association270, pp. 2948–2954.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoedemaekers, R., ten Have, H. Commercialisation of genetic diagnostic services. Med Health Care Philos 1, 217–224 (1998). https://doi.org/10.1023/A:1009913008908

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009913008908

Keywords

Navigation